×
About 26,453 results

ALLMedicine™ Mild Cognitive Impairment Center

Research & Reviews  8,742 results

Trajectories of physical functioning among US adults with cognitive impairment.
https://doi.org/10.1093/ageing/afac139
Age and Ageing; Zang E, Shi Y et. al.

Jun 26th, 2022 - physical functioning impairment is common among persons with cognitive impairment, but little is known about physical functioning trajectories across the US population or how trajectories may differ among persons with dementia and mild cognitive i...

The Link between Cutaneous Inflammation and Cognitive Impairment.
https://doi.org/10.1111/jdv.18360
Journal of the European Academy of Dermatology and Venere... Wen S, Elias PM et. al.

Jun 25th, 2022 - Cognitive impairment is a symptom of neurological disorders, including dementia and Alzheimer's disease; and mild cognitive impairment can be a precursor of both disorders. Aged humans and animal models with other systemic disorders, such as cardi...

Does essential tremor increase the risk of dementia? No.
https://doi.org/10.1016/bs.irn.2022.02.012
International Review of Neurobiology; Rajput A

Jun 25th, 2022 - Essential tremor (ET) is the most common neurological cause of tremor affecting adult humans affecting about 6% of those over age 65 years. In the United States, dementia has a prevalence of 15% in those age 68 and older. Overlap of the two condit...

Enhancing neurocognitive health, abilities, networks, & community engagement for older ...
https://doi.org/10.1080/17483107.2022.2087770
Disability and Rehabilitation. Assistive Technology; Sanders EC, Stuart R et. al.

Jun 25th, 2022 - Age associated cognitive impairments (CIs) result in difficulties with a wide range of daily activities. As the older adult population increases, so does the importance of understanding and supporting the needs and disabilities of those with CIs. ...

see more →

Guidelines  6 results

The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis
https://pubmed.ncbi.nlm.nih.gov/35128762/
Psychogeriatrics Soysal P, Smith L et. al.

Feb 6th, 2022 - The COVID-19 pandemic may have a disproportionate impact on people with dementia/mild cognitive impairment (MCI) due to isolation and loss of services. The aim of this systematic review was to investigate the effects of the COVID-19 lockdown on ne...

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force R...
https://doi.org/10.1001/jama.2020.0435
JAMA , Owens DK et. al.

Feb 26th, 2020 - Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individual...

Treatment of dementia and mild cognitive impairment with or without cerebrovascular dis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488894
CNS Neuroscience & Therapeutics; Kandiah N, Ong PA et. al.

Jan 17th, 2019 - The Ginkgo biloba special extract, EGb 761® has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer's disease (AD). To guide clinical practice in the Asian region, the Asian Clinical Expert Group on Neurocognitive ...

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline D...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772157
Neurology Petersen RC, Lopez O et. al.

Dec 29th, 2017 - To update the 2001 American Academy of Neurology (AAN) guideline on mild cognitive impairment (MCI). The guideline panel systematically reviewed MCI prevalence, prognosis, and treatment articles according to AAN evidence classification criteria, a...

Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force...
https://doi.org/10.7326/M14-0496
Annals of Internal Medicine; Moyer VA,

Mar 26th, 2014 - Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for dementia. The USPSTF reviewed the evidence on the benefits, harms, and sensitivity and specificity of screening instruments for cognitive impairment in...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  900 results

The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment
https://clinicaltrials.gov/ct2/show/NCT04073628

Jun 24th, 2022 - The current application proposes to investigate the impact of a long-term light treatment intervention on sleep physiology and sleep-dependent cognitive processes in mild cognitive impairment (MCI) and mild Alzheimer's disease (AD) patients. The p...

A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
https://clinicaltrials.gov/ct2/show/NCT04867616

Jun 24th, 2022 - The purpose of the study is to investigate the effect of bepranemab versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study participants with prodromal or mild Alzheimer's Disease (AD).

A Scalable Model for Promoting Functioning and Well-Being Among Older Adults With Mild Cognitive Impairment Via Meaningful Social Interactions: Project SPEAK!
https://clinicaltrials.gov/ct2/show/NCT04717479

Jun 24th, 2022 - Aim 1: Conduct a user-centered design process to refine the SPEAK! training protocols for older adults with symptoms of SCD/MCI and ELLs, and the materials that will support productive engaging English conversation practice. Aim 2: Conduct a rando...

Mind Your Heart-II
https://clinicaltrials.gov/ct2/show/NCT05431192

Jun 24th, 2022 - Stable outpatients patients with co-morbid heart failure (HF) and mild cognitive impairment (MCI) (n=176) will be randomly assigned to phone-delivered MT (a weekly, 30-minute session for 8 weeks integrated with 20-min daily guided individual pract...

A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT05104463

Jun 24th, 2022 - Approximately 40 subjects will be enrolled in a 2 period, 2-way crossover design following study eligibility confirmation during the screening period. During each treatment period, subjects will receive daily doses of CST-2032 administered with CS...

see more →

News  920 results

Sleep Tied to Objective and Subjective Cognition
https://www.medscape.com/viewarticle/976115

Jun 23rd, 2022 - Amy Costa Poor objective sleep efficiency may contribute to older adults overestimating their cognitive abilities, preliminary findings from a pilot study of objective and subjective cognitive measures have shown. The pilot study underscored the i...

Vulnerable Brain Networks Predict Alzheimer's Disease
https://www.medscape.com/viewarticle/976033

Jun 22nd, 2022 - The study covered in this summary was published on bioRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaway Identification of network-based biomarkers associated with Alzheimer's disease (AD) can allow for early, effective interv...

An Imminent Risk Factor for Alzheimer's Disease?
https://www.medscape.com/viewarticle/974596

May 25th, 2022 - The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The clinical value of biologic criteria ― global amyloid burden (A), composite of temporal region of tau PET uptake (T),...

see more →

Patient Education  10 results see all →